General Hospital Vienna is the largest radiotherapy center in Austria, and treats approximately 3,000 radiotherapy patients per year. The capability to perform VMAT offers a tremendous advantage for the hospital and its patients, says Chief Medical Doctor Professor Richard Potter. "The new system will revolutionize tailored intensity modulated radiotherapy during the next decade. Very soon, not only head and neck lesions will be treated with VMAT, but also tumors in the lung, close to the cervical spine and in the pelvis."
"What I've seen so far is the possibility that we can, in the long term, treat more patients, because we have a more efficient workflow and much faster treatments," says Dr. Georg. "We are at the forefront of the leading radio- oncology hospitals in the world. VMAT will give us an enormous impetus both scientifically and in medical care."
*Elekta Volumetric Intensity Modulated Arc Therapy (VMAT) is pending regulatory approvals in certain markets, including 510(k) clearance in the US, and is not yet available for commercial sale in the US.
Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state-of-the-art tools to fight serious disease.
Elekta provides advanced clinical solutions and comprehensive management and information systems, as well as services for improved cancer care and management of brain disorders.
Elekta's systems and solutions are used in over 4,500 hospitals around
the world. Clinical and information management solutions include, among
others, Leksell Gamma Knife(R) for non-invasive treatment of brain
disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and
image guided radiation therapy and radiosurgery, as well as the MOSAIQ(TM)
suite of software for image-enabled EMR and
|SOURCE Elekta, Inc.|
Copyright©2008 PR Newswire.
All rights reserved